pamidronate has been researched along with Episcleritis in 6 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "We present a case of severe unilateral posterior scleritis associated with zoledronic acid administration that was recognized and treated in a timely manner." | 8.83 | Scleritis complicating zoledronic acid infusion. ( Badros, A; Benderson, D; Karakunnel, J; Kathuria, S, 2006) |
| "To evaluate reported cases of scleritis and other ocular side effects associated with pamidronate disodium, with emphasis on previously unreported cases of scleritis." | 7.72 | Scleritis and other ocular side effects associated with pamidronate disodium. ( Fraunfelder, FT; Fraunfelder, FW; Jensvold, B, 2003) |
| "We present a case of severe unilateral posterior scleritis associated with zoledronic acid administration that was recognized and treated in a timely manner." | 4.83 | Scleritis complicating zoledronic acid infusion. ( Badros, A; Benderson, D; Karakunnel, J; Kathuria, S, 2006) |
| "To evaluate reported cases of scleritis and other ocular side effects associated with pamidronate disodium, with emphasis on previously unreported cases of scleritis." | 3.72 | Scleritis and other ocular side effects associated with pamidronate disodium. ( Fraunfelder, FT; Fraunfelder, FW; Jensvold, B, 2003) |
| " Pamidronate, an inhibitor of bone resorption used primarily in the management of tumor-induced hypercalcemia and Paget's disease, is reported to cause conjunctivitis, anterior uveitis, and infrequently episcleritis and scleritis." | 3.72 | Posterior uveitis: an under-recognized adverse effect of pamidronate: 2 case reports. ( Claes, C; Haverbeke, G; Pertile, G; Zeyen, T, 2003) |
| "Uveitis and scleritis are the most serious ocular side effects of bisphosphonate therapy." | 1.35 | Postmarketing surveillance rates of uveitis and scleritis with bisphosphonates among a national veteran cohort. ( French, DD; Margo, CE, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 5 (83.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| French, DD | 1 |
| Margo, CE | 1 |
| Fraunfelder, FW | 2 |
| Winthrop, K | 1 |
| Suhler, E | 1 |
| Choi, D | 1 |
| Fraunfelder, FT | 3 |
| Jensvold, B | 1 |
| Haverbeke, G | 1 |
| Pertile, G | 1 |
| Claes, C | 1 |
| Zeyen, T | 1 |
| Benderson, D | 1 |
| Karakunnel, J | 1 |
| Kathuria, S | 1 |
| Badros, A | 1 |
| Macarol, V | 1 |
1 review available for pamidronate and Episcleritis
| Article | Year |
|---|---|
Scleritis complicating zoledronic acid infusion.
Topics: Aged; Anti-Inflammatory Agents; Bone Density Conservation Agents; Diphosphonates; Humans; Imidazoles | 2006 |
5 other studies available for pamidronate and Episcleritis
| Article | Year |
|---|---|
Postmarketing surveillance rates of uveitis and scleritis with bisphosphonates among a national veteran cohort.
Topics: Administration, Oral; Aged; Aged, 80 and over; Alendronate; Bone Density Conservation Agents; Databa | 2008 |
Postmarketing surveillance rates of uveitis and scleritis with bisphosphonates among a national veteran cohort.
Topics: Administration, Oral; Alendronate; Bone Density Conservation Agents; Databases, Factual; Diphosphona | 2009 |
Scleritis and other ocular side effects associated with pamidronate disodium.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Conjunctivitis; Diphosphonates; Female; Humans; Male | 2003 |
Posterior uveitis: an under-recognized adverse effect of pamidronate: 2 case reports.
Topics: Bone Neoplasms; Bone Resorption; Carcinoma; Conjunctivitis; Diphosphonates; Fatal Outcome; Humans; M | 2003 |
Pamidronate disodium and possible ocular adverse drug reactions.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Conjunctivitis; Diphosphonates; Drug Hypersensitivity; H | 1994 |